Fourteen days struggling to deal with COVID-19 using Su Jok Therapy: A case report

https://doi.org/10.22146/jcoemph.66453

Intansari Nurjannah(1*)

(1) Department of Mental Health and Community Nursing, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia
(*) Corresponding Author

Abstract


The resources to deal with COVID-19 are lessening, while health professionals are increasingly vulnerable in helping people with COVID-19. The close contact between health professionals and patients with COVID-19 increases the already high risk for transmission. It is time to find another form of therapy to help people with COVID-19 which is effective, inexpensive, easy and safe that can be done both for the well-being of patients and health professionals. In 2020, a male patient who was in his middle age, was seeking treatment from health professionals by sending messages through WhatsApp since he tested positive for COVID-19 the day before. We assessed him and found that he had complaints of fever, shivering and difficulty in breathing. We immediately replied with Su Jok protocol therapy and asked him to do the treatment by himself. After 27 minutes, there was no difficulty in breathing anymore. Since then, we kept monitoring his condition closely and provided instructions every day to treat each symptom. The most prominent symptoms associated with COVID-19 were shivering, difficulty in breathing, fever, excess mucus and pain in the lungs. Psychological symptoms also appeared and Su Jok was applied to treat his emotional problems. Symptoms attacked him less frequently and with less severity day by day. His swab test showed negative result after two weeks. In this case study, Su Jok therapy helped a patient in quarantine to deal with the physiological and psychological symptoms of COVID-19. Su Jok therapy can also help to prevent transmission of COVID-19 to health professionals, since they still can help patients from a distance with telehealth.


Keywords


COVID-19 Pandemic; Su Jok; telehealth

Full Text:

PDF


References

1. Park JW. Be Your Own Doctor. Jaipur, India: Smile Academy Pvt. Ltd; 1987.

2. Leyva González M, Benítez González Y, Gutiérrez Aguilera N, Cruz Torres W, Cruz Batista M. Presentation of a patient with elbow hygrome treated with Sujok acupuncture. Correo Científico Médico de Holguín. 2017;21(2):570-6.

3. Safonov M, Naprienko M. Analysis of the efficacy of reflexology in the complex treatment of chronic migraine. Zhurnal Nevrologii i Psikhiatrii Imeni SS Korsakova. 2017;117(5):22-5.

4. Ubaĭdullaev A, Sharafutdinova G, Ismailov S. Treatment of bronchial asthma by the Su-Jok therapy method. Terapevticheskii Arkhiv. 1998;70(12):44-6.

5. Trujillo Huber JC, Pereira Despaigne OL, Jacas García C, García Díaz RdlC. Efectividad de la terapia Su-Jok en pacientes con dolor por espolón calcáneo. Medisan. 2016;20(10):2258-66.

6. Yagil Z. Sujok therapy for the treatment of fatigue and weakness among oncologic patients. Quaderno. 2019;14(23):51-69.

7. Nurjannah I, Hariyadi K. Sujok as a complementary therapy for reducing level of pain: a retrospective study. Complementary Therapies in Clinical Practice. 2021:101337.

8. Park JW. The Six Energy Theory Illustrated Handbook. Jaipur, India: Smile Academy Pvt. Ltd.; 2002.

9. Park JW. Atlas of the Energy System of the Human Body. Jaipur, India: Su Jok Therapy Center Pvt. Ltd; 2007.

10. Nurjannah I. “Su Jok” therapy and sclerology profile monitoring for managing chest pain at home while avoiding hospital admission during the COVID-19 pandemic: a case study. Belitung Nursing Journal. 2020;6(6):229-32.

11. Park JW. Su Jok Seed Therapy. India: Su Jok Therapy Centre (India) Pvt. Ltd; 2000.

12. Park JW. Triorigin Acupuncture. 1 V, editor. Jaipur, India: Smile Academy; 2008.



DOI: https://doi.org/10.22146/jcoemph.66453

Article Metrics

Abstract views : 235 | views : 127

Refbacks

  • There are currently no refbacks.


Copyright (c) 2022 Journal of Community Empowerment for Health

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.